Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

INCOME TAXES (Tables)

v3.10.0.1
INCOME TAXES (Tables)
12 Months Ended
Sep. 30, 2018
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
 
 
As of September 30,
 
 
 
2018
 
 
2017
 
 
2016
 
Deferred tax assets:
 
 
 
 
 
 
 
 
 
 
 
 
Bad debt allowance recorded for accounts receivable
 
$
299,596
 
 
$
272,557
 
 
$
247,227
 
Net operating loss carry-forward
 
 
152,257
 
 
 
-
 
 
 
-
 
Less: valuation allowance
 
 
(152,257
)
 
 
-
 
 
 
-
 
Total
 
$
299,596
 
 
$
272,557
 
 
$
247,227
 
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Income taxes for the years ended September 30, 2018 and 2017 are attributed to the Company’s continuing operations in China and consisted of:
 
 
 
For the year ended September 30,
 
 
 
2018
 
 
2017
 
 
2016
 
Current
 
$
1,435,521
 
 
$
1,019,147
 
 
$
1,209,114
 
Deferred
 
 
(37,311
)
 
 
(24,142
)
 
 
(103,674
)
Total
 
$
1,398,210
 
 
$
995,005
 
 
$
1,105,440
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Per the consolidated statements of operations and comprehensive income, the income tax expenses for the Company can be reconciled to the income before income taxes for the years ended September 30, 2018 and 2017 as follows:
 
 
 
 
For the year ended September 30,
 
 
 
2018
 
 
2017
 
Income before taxes excluded the amounts of loss incurring entities
 
$
9,982,326
 
 
$
7,178,353
 
PRC EIT tax rates
 
 
15
%
 
 
15
%
Tax at the PRC EIT tax rates
 
 
1,497,349
 
 
 
1,076,753
 
Tax effect of 50% R&D expenses deduction
 
 
(123,948
)
 
 
(99,833
)
Tax effect of deferred tax recognized
 
 
(37,311
)
 
 
(24,142
)
Tax effect of non-deductible expenses
 
 
62,120
 
 
 
42,227
 
Income tax expenses
 
$
1,398,210
 
 
$
995,005